Philip Taylor | Investor Relations |
Drew Spaventa | Founder and Chief Executive Officer |
Dalen Meeter | Chief Financial Officer |
John Sourbeer | UBS |
Matt Sykes | Goldman Sachs |
Daniel Brennan | Cowen & Co. |
Greetings, and welcome to the Singular Genomics Systems, Incorporated Fourth Quarter 2022 Earnings Conference Call.[Operator Instructions] Please note, this conference is being recorded.
I will now turn the conference over to your host, Mr. Philip Taylor. Sir, you may begin.
Thank you, operator.